Referências 172
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT,
Chance PF, Ochs HD. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked
syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001, 27(1):20-21.
Ben-Nun A, Cohen IR. Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines:
process of selection of lines and characterization of the cells. J Immunol. 1982, 129(1):303-308.
Berzins SP, Godfrey DI, Miller JF, Boyd RL. A central role for thymic emigrants in peripheral T cell
homeostasis. Proc Natl Acad Sci USA. 1999, 96(17):9787-9791.
Berzins SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI, Boyd RL. Thymic regeneration:
teaching an old immune system new tricks. Trends Mol. Med. 2002, 8(10):469-476.
Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the
general population: strategies based on combinations of autoantibody markers. Diabetes 1997,
46(11):1701-1710.
Bluestone JA and Abbas AK. Natural versus adaptive regulatory T cells. Nature Rev Immunol 2003,
3(3):253-257.
Bougnères F, Landais P, Boisson C, Carel JC, Frament N, Boitard C, Chaussain JL, Bach JF. Limited
duration of remission of insulin dependency in children with recent overt type I diabetes treated with
low-dose cyclosporin. Diabetes 1990, 39(1):1264-1272.
Boyum, A. Separation of blood leukocytes, granulocytes and lymphocytes. Tissue Antigens 1974,
4(4):269-274.
Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J,
Migueles SA, Connors M, Roederer M, Douek DC, Koup RA. Expression of CD57 defines replicative
senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003, 101(7):2711-2720.
Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D,
Ziegler SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal
lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001, 27(1):68-73.
Burt RK, Cohen B, Rose J, Petersen F, Oyama Y, Stefoski D, Katsamakis G, Carrier E, Kozak T,
Muraro PM, Martin R, Hintzen R, Slavin S, Karussis D, Haggiag S, Voltarelli JC, Ellison GW,
Jovanovic B, Popat U, McGuirk J, Statkute L, Verda L, Haas J, Arnold R. Hematopoietic stem cell
transplantation for multiple sclerosis. Arch Neurol 2005, 62(6): 860-864.
Burt RK, Kenyon N, Voltarelli JC, Kaufman DB. Hematopoietic stem cell transplantation as treatment
for type 1 diabetes. In: Burt RK and Marmont A (eds). Stem cell therapy for autoimmune diseases.
Landes Biociences, Georgetown, Texas, USA, 2004.
Burt RK, Oyama Y, Traynor A, Kenyon NS. Hematopoietic stem cell therapy for type 1 diabetes:
induction of tolerance and islet cell neogenesis. Autoimmun Rev. 2002a, 1(3):133-138.
Burt RK, Padilla J, Begolka WS, Canto MC, Miller SD. Effect of disease stage on clinical outcome after
syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis.
Blood 1998a, 91(7):2609-2616.
Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by
hematopoeitic stem cell transplantation: getting closer to a cure? Blood 2002b, 99(3):768-784.
Burt RK, Traynor AE, Craig R, Marmont AM. The promise of hematopoietic stem cell transplantation
for autoimmune diseases. Bone Marrow Transplantation 2003, 31(7):521-524.
Burt RK, Traynor AE, Pope R, Schroeder J, Cohen B, Karlin KH, Lobeck L, Goolsby C, Rowlings P,
Davis FA, Stefoski D, Terry C, Keever-Taylor C, Rosen S, Vesole D, Fishman M, Brush M, Mujias S,